Protective effect of silymarin against chemical-induced cardiotoxicity

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 140

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-19-9_001

تاریخ نمایه سازی: 30 مهر 1400

Abstract:

Cardiac disorders remain one of the most important causes of death in the world. Oxidative stress has been suggested as one of the molecular mechanisms involved in drug-induced cardiac toxicity. Recently, several natural products have been utilized in different studies with the aim to protect the progression of oxidative stress-induced cardiac disorders. There is a large body of evidence that administration of antioxidants may be useful in ameliorating cardiac toxicity. Silymarin, a polyphenolic flavonoid has been shown to have utility in several cardiovascular disorders. In this review, various studies in scientific databases regarding the preventive effects of silymarin against cardiotoxicity induced by chemicals were introduced. Although there are many studies representing the valuable effects of silymarin in different diseases, the number of researches relating to the possible cardiac protective effects of silymarin against drugs induced toxicity is rather limited. Results of these studies show that silymarin has a broad spectrum of cardiac protective activity against toxicity induced by some chemicals including metals, environmental pollutants, oxidative agents and anticancer drugs. Further studies are needed to establish the utility of silymarin in protection against cardiac toxicity.

Authors

Bibi Marjan Razavi

Targeted Drug Delivery Research Center, Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Gholamreza Karimi

Pharmaceutical Research Center, Pharmacy School, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ۱.Negi A, Kumar J, Luqman S, Shanker K, Gupta M, ...
  • ۲.Luper S. A review of plants used in the treatment ...
  • ۳.Pepping J. Milk thistle: Silybum marianum, . Am J Health ...
  • ۴.Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. ...
  • ۵.Dixit N, Baboota S, Kohli K, Ahmad S, Ali J. ...
  • ۶.Karimi G, Hassanzadeh M, Mehri S. Protective effects of Silymarin ...
  • ۷.Nazemian F. Effect of silymarin administration on TNF-α serum concentration ...
  • ۸.Ramakrishnan G, Lo Muzio L, Elinos-Báez CM, Jagan S, Augustine ...
  • ۹.Taghiabadi T, Imenshahidi M, Abnous K, Mosafa F, Sankian M, ...
  • ۱۰.Muthumani M, Milton Prabu S. Silibinin potentially attenuates arsenic-induced oxidative ...
  • ۱۱.Karimi G, Saradeghi Keisari M. Evaluation of antidepressant effect of ...
  • ۱۲.Morishima C, Shuhart M, Wang CC, Paschal D, Apodaca M, ...
  • ۱۳.Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection ...
  • ۱۴.Karimi G, Fallah Huseini H, Ramezani M, Tahoonian Z. Protective ...
  • ۱۵.Chu S, Chiou H, Chen P, Yang S, Hsieh Y. ...
  • ۱۶.Kanter M, Meral I, Yener Z. Partial regeneration/ proliferation of ...
  • ۱۷.Toklu H, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, ...
  • ۱۸.Saller R, Melzer J, Reichling J, Brignoli R, Meier R. ...
  • ۱۹.Fleming T. PDR for Herbal Medicines. New Jersy Medical Economics ...
  • ۲۱.Rao P, Viswanath R. Cardioprotective activity of silymarin in ischemia-reperfusion-induced ...
  • ۲۲.Talha J, Priyanka M A A. Hypertension and herbal plants. ...
  • ۲۳.Sinha M, Manna P, SIL P. Terminalia arjuna protects mouse ...
  • ۲۴.Nabavi S, Moghaddam A, Setzer W, Mirzaei M. Effect of ...
  • ۲۵.Murphy C. G. Oudit. Iron-overload cardiomyo-pathy: Pathophysiology, diagnosis, and treatment. ...
  • ۲۶.Wang Y, Wu M, Al-Rousan R, Liu H, Fannin J, ...
  • ۲۷.Borsari M, Gabbi C, Ghelfi F, Grandi R, Saladini M, ...
  • ۲۸.Gharagozloo M, Khoshdel Z, Amirghofran Z. The effect of an ...
  • ۲۹.Najafzadeh H, Jalali M, Morovvati H, Taravati F. Comparison of ...
  • ۳۰.Navidi-Shishaone M, Mohhebi S, Nematbakhsh M, Roozbehani S, Talebi A, ...
  • ۳۱.Moon K, Guallar E, Navas–Acien A. Arsenic Exposure and Cardiovascular ...
  • ۳۲.Manna P, Sinha MPS. Arsenic induced oxidative myocardial injury: Protective ...
  • ۳۳.Alamolhodaei NS, Shirani K, Karimi G. Arsenic cardiotoxicity: An overview. ...
  • ۳۴.Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, ...
  • ۳۵.Dutta M, Ghosh A, Rangari V, Jain G, Khobragade S, ...
  • ۳۶.Miltonprabu S, Thangapandiyan S. Epigallocatechin gallate potentially attenuates Fluoride induced ...
  • ۳۷.Shashi A, Thapar S. Histopathology of myocardial damage in experimental ...
  • ۳۸.Donmez N, Cinar A. Effects of chronic fluorosis on electrocardiogram ...
  • ۳۹.Nabavi S, Nabavi SF, Eslami S, Moghaddam A. In vivo ...
  • ۴۰.Ma Y, Niu R, Sun Z, Wang J, Luo G, ...
  • ۴۱.Diwan A, Dorn G. Decompensation of cardiac hypertrophy: cellular mechanisms ...
  • ۴۲.Molkentin J, Dorn G. Cytoplasmic signaling pathways that regulate cardiac ...
  • ۴۳.Bernardo B. Molecular distinction between physiological and pathological cardiac hypertrophy: ...
  • ۴۴.Takimoto E, Kass D. Role of oxidative stress in cardiac ...
  • ۴۵.Anestopoulos I, Kavoa A, Tentesc I, Kortsarisc A, Panayiotidisd M, ...
  • ۴۶.Cieslak D, Lazou A. Regulation of BAD protein by PKA, ...
  • ۴۷.Communal C. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes ...
  • ۴۸.Zhou B, Wu L, Li L, Tashiro S, Onodera S, ...
  • ۴۹.Zhou B, Wu L, Tashiro S, Onodera S, Uchiumi F, ...
  • ۵۰.Zhou B, Wu L, Tashiro S, Onodera S, Uchiumi F, ...
  • ۵۱.Faroon O, Roney N, Taylor J, Ashizawa A, Lumpkin M, ...
  • ۵۲.Stevens J, Maier C. Acrolein: sources, metabolism, and biomolecular interactions ...
  • ۵۳.Raschi E, Vasina V, Ursino M. Anticancer drugs and cardiotoxicity: ...
  • ۵۴.Ado R, de Keulenaer G, Leite-Moreira A, Brs-Silva C. Cardiotoxicity ...
  • ۵۵.Blum R, Carter S. Adriamycin. A new anticancer drug with ...
  • ۵۶.El-Shitany N, El-Haggar S, El-desoky K. Silymarin prevents adriamycin-induced cardiotoxicity ...
  • ۵۷.Chlopcikova S, Psotová P, Miketová P, Šimánek V. Chemoprotective Effect ...
  • ۵۸.Cecen E, Dost T, Culhaci N, Karul A, Ergur B, ...
  • ۵۹.Psotová J, Chlopčíková S, Grambal F, Šimánek V, Ulrichová J. ...
  • ۶۰.El-Awady E, Moustafa Y, Abo-Elmatty D, Radwan A. Cisplatin-induced cardiotoxicity: ...
  • نمایش کامل مراجع